Sumary of New method predicts if COVID-19 clinical trials will be completed or suspended:
- In order to win the battle against COVID-19, studies to develop vaccines, drugs, devices and re-purposed drugs are urgently needed.
- Randomized clinical trials are used to provide evidence of safety and efficacy as well as to better understand this novel and evolving virus.
- As of July 15, more than 6,180 COVID-19 clinical trials have been registered through ClinicalTrials.
- gov, the national registry and database for privately and publicly funded clinical studies conducted around the world.
- Researchers from Florida Atlantic University’s College of Engineering and Computer Science are the first to model COVID-19 completion versus cessation in clinical trials using machine learning algorithms and ensemble learning.
- The study, published in PLOS One, provides the most extensive set of features for clinical trial reports, including features to model trial administration, study information and design, eligibility, keywords, drugs and other features.
- This research shows that computational methods can deliver effective models to understand the difference between completed vs.
- In addition, these models also can predict COVID-19 trial status with satisfactory accuracy.